These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 2668352
1. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects. Fujimura A, Ohashi K, Tsuru M, Ebihara A, Kondo K. J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352 [Abstract] [Full Text] [Related]
3. Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension. Fujimura A, Sugimoto K, Kumagai Y, Nakashima H, Ebihara A. J Clin Pharmacol; 1989 Nov; 29(11):1008-12. PubMed ID: 2574727 [Abstract] [Full Text] [Related]
4. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol. Donnelly R, Macphee GJ. Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570 [Abstract] [Full Text] [Related]
7. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations. Given BD, Perentesis G, Christopher JD, Herron J, Patrick JE, Kramer WG, Affrime MB. Am J Cardiol; 1989 Jun 05; 63(19):12I-16I. PubMed ID: 2729123 [Abstract] [Full Text] [Related]
8. Secretion of dilevalol in breast milk. Radwanski E, Nagabhushan N, Affrime MB, Perentesis G, Symchowicz S, Patrick JE. J Clin Pharmacol; 1988 May 05; 28(5):448-53. PubMed ID: 2899094 [Abstract] [Full Text] [Related]
9. Dilevalol: a dose-response study in normal volunteers. Walden RJ, Graham BR, Liu JB, Prichard BN. J Hum Hypertens; 1990 Jun 05; 4 Suppl 2():69-75. PubMed ID: 2196371 [Abstract] [Full Text] [Related]
10. Acute hormonal and renal effects of oral dilevalol in normal men. Whitworth JA, Gordon D, Harpley R, Yeung S, Phillips P. Clin Exp Pharmacol Physiol; 1989 Jan 05; 16(1):59-63. PubMed ID: 2523264 [Abstract] [Full Text] [Related]
11. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension. Drici MD, Candito M, Ferrari E, Jacomet Y, Morand P, Lapalus P. Int J Clin Pharmacol Ther Toxicol; 1991 Sep 05; 29(9):361-5. PubMed ID: 1937998 [Abstract] [Full Text] [Related]
12. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man. Tham TC, McKaigue JP, Guy S, Shanks RG, Riddell JG. Br J Clin Pharmacol; 1993 Sep 05; 36(3):251-6. PubMed ID: 9114912 [Abstract] [Full Text] [Related]
13. Clinical pharmacology of dilevalol (i.v.). Influence of hepatic and renal functions on the disposition of dilevalol and atenolol in hypertensive subjects. Kotegawa T, Fujimura A, Ebihara A. J Clin Pharmacol; 1990 May 05; 30(5):404-8. PubMed ID: 2347954 [Abstract] [Full Text] [Related]
14. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release. Lammintausta R, Koulu M, Allonen H. Int J Clin Pharmacol Biopharm; 1979 Jun 05; 17(6):240-43. PubMed ID: 38214 [Abstract] [Full Text] [Related]
18. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients. Walley T, Tsao Y, Scott A, Mackay E, Vandenburg M, Breckenridge A. Br J Clin Pharmacol; 1993 Jun 05; 35(6):623-8. PubMed ID: 8329290 [Abstract] [Full Text] [Related]